PNMA2 and paraneoplastic neurologic syndrome: Indeed, the same paraneoplastic “high-risk” Abs (e.g., anti-Hu, anti-Ma2) can be found in LE triggered by cancer immunotherapy, suggesting a common immunopathological background between this type of irAEs and naturally occurring paraneoplastic neurological syndromes (PNS).